183 related articles for article (PubMed ID: 26427432)
1. Can Vitamin A be Improved to Prevent Blindness due to Age-Related Macular Degeneration, Stargardt Disease and Other Retinal Dystrophies?
Saad L; Washington I
Adv Exp Med Biol; 2016; 854():355-61. PubMed ID: 26427432
[TBL] [Abstract][Full Text] [Related]
2. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization.
Charbel Issa P; Barnard AR; Herrmann P; Washington I; MacLaren RE
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8415-20. PubMed ID: 26106163
[TBL] [Abstract][Full Text] [Related]
3. C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease.
Ma L; Kaufman Y; Zhang J; Washington I
J Biol Chem; 2011 Mar; 286(10):7966-7974. PubMed ID: 21156790
[TBL] [Abstract][Full Text] [Related]
4. Deuterium enrichment of vitamin A at the C20 position slows the formation of detrimental vitamin A dimers in wild-type rodents.
Kaufman Y; Ma L; Washington I
J Biol Chem; 2011 Mar; 286(10):7958-7965. PubMed ID: 21075840
[TBL] [Abstract][Full Text] [Related]
5. The Rate of Vitamin A Dimerization in Lipofuscinogenesis, Fundus Autofluorescence, Retinal Senescence and Degeneration.
Washington I; Saad L
Adv Exp Med Biol; 2016; 854():347-53. PubMed ID: 26427431
[TBL] [Abstract][Full Text] [Related]
6. Stargardt macular dystrophy and evolving therapies.
Hussain RM; Ciulla TA; Berrocal AM; Gregori NZ; Flynn HW; Lam BL
Expert Opin Biol Ther; 2018 Oct; 18(10):1049-1059. PubMed ID: 30129371
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of retinal disease with visual cycle modulators.
Hussain RM; Gregori NZ; Ciulla TA; Lam BL
Expert Opin Pharmacother; 2018 Apr; 19(5):471-481. PubMed ID: 29542350
[TBL] [Abstract][Full Text] [Related]
8. C20D3-Vitamin A Prevents Retinal Pigment Epithelium Atrophic Changes in a Mouse Model.
Zhang D; Robinson K; Washington I
Transl Vis Sci Technol; 2021 Dec; 10(14):8. PubMed ID: 34878528
[TBL] [Abstract][Full Text] [Related]
9. Vitamin A in Stargardt disease-an evidence-based update.
Federspiel CA; Bertelsen M; Kessel L
Ophthalmic Genet; 2018 Oct; 39(5):555-559. PubMed ID: 29939824
[TBL] [Abstract][Full Text] [Related]
10. Morphological and physiological retinal degeneration induced by intravenous delivery of vitamin A dimers in rabbits.
Penn J; Mihai DM; Washington I
Dis Model Mech; 2015 Feb; 8(2):131-8. PubMed ID: 25504631
[TBL] [Abstract][Full Text] [Related]
11. [New possibilities in the treatment of Stargardt disease].
Zhorzholadze NV; Sheremet NL; Tanas AS; Strelnikov VV
Vestn Oftalmol; 2020; 136(4. Vyp. 2):333-343. PubMed ID: 32880159
[TBL] [Abstract][Full Text] [Related]
12. Vitamin A dimers trigger the protracted death of retinal pigment epithelium cells.
Mihai DM; Washington I
Cell Death Dis; 2014 Jul; 5(7):e1348. PubMed ID: 25058422
[TBL] [Abstract][Full Text] [Related]
13. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation.
Radu RA; Yuan Q; Hu J; Peng JH; Lloyd M; Nusinowitz S; Bok D; Travis GH
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3821-9. PubMed ID: 18515570
[TBL] [Abstract][Full Text] [Related]
14. Experimental studies on medical treatments of retinal dystrophies with a particular focus on ABCA4 retinopathies.
Sciezynska A; Ozieblo D; Oldak M
Klin Oczna; 2016 Aug; 118(1):59-65. PubMed ID: 29715411
[TBL] [Abstract][Full Text] [Related]
15. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.
Yeong JL; Loveman E; Colquitt JL; Royle P; Waugh N; Lois N
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013154. PubMed ID: 33331670
[TBL] [Abstract][Full Text] [Related]
16. Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease.
Wu Y; Fishkin NE; Pande A; Pande J; Sparrow JR
J Biol Chem; 2009 Jul; 284(30):20155-66. PubMed ID: 19478335
[TBL] [Abstract][Full Text] [Related]
17. Experimenal studies On cell and gene therapies for retinal dystrophies with a particular focus On ABCA4 retinopathies.
Sciezynska A; Ozieblo D; Oldak M
Klin Oczna; 2016 Aug; 118(1):66-71. PubMed ID: 29715412
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A cycle byproducts explain retinal damage and molecular changes thought to initiate retinal degeneration.
Zhang D; Mihai DM; Washington I
Biol Open; 2021 Nov; 10(11):. PubMed ID: 34842275
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of the di-apocarotenoid norbixin (BIO201) is neuroprotective, preserves photoreceptor function and inhibits A2E and lipofuscin accumulation in animal models of age-related macular degeneration and Stargardt disease.
Fontaine V; Monteiro E; Fournié M; Brazhnikova E; Boumedine T; Vidal C; Balducci C; Guibout L; Latil M; Dilda PJ; Veillet S; Sahel JA; Lafont R; Camelo S
Aging (Albany NY); 2020 Apr; 12(7):6151-6171. PubMed ID: 32255762
[TBL] [Abstract][Full Text] [Related]
20. Bisretinoid Photodegradation Is Likely Not a Good Thing.
Ueda K; Kim HJ; Zhao J; Sparrow JR
Adv Exp Med Biol; 2018; 1074():395-401. PubMed ID: 29721969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
